CID 509452

Schembl7484749

Structural Information

Molecular Formula
C32H38N4OS
SMILES
CC(C)C1=CC(=C(C(=C1)C(C)C)C(=O)NC2=NN=C(S2)NCC(C3=CC=CC=C3)C4=CC=CC=C4)C(C)C
InChI
InChI=1S/C32H38N4OS/c1-20(2)25-17-26(21(3)4)29(27(18-25)22(5)6)30(37)34-32-36-35-31(38-32)33-19-28(23-13-9-7-10-14-23)24-15-11-8-12-16-24/h7-18,20-22,28H,19H2,1-6H3,(H,33,35)(H,34,36,37)
InChIKey
RYNMAWYFXZZUSK-UHFFFAOYSA-N
Compound name
N-[5-(2,2-diphenylethylamino)-1,3,4-thiadiazol-2-yl]-2,4,6-tri(propan-2-yl)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

526.2766 Da
Monoisotopic Mass

8.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 527.28388 230.5
[M+Na]+ 549.26582 232.2
[M-H]- 525.26932 240.0
[M+NH4]+ 544.31042 234.5
[M+K]+ 565.23976 225.7
[M+H-H2O]+ 509.27386 219.2
[M+HCOO]- 571.27480 242.0
[M+CH3COO]- 585.29045 254.4
[M+Na-2H]- 547.25127 223.5
[M]+ 526.27605 232.8
[M]- 526.27715 232.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe